Updated 20:08 GMT, 15 Nov 2026 SPX 7,561.67 -0.40% NDX 27,943.74 -1.22% VIX 19.30 +3.21% GOLD 3,886.30 +0.03% CL 88.56 -0.20% BTC 64,770.01 +1.00%
NAS100 27,944 −1.22% S&P 7,562 −0.40% GOLD $3,886 +0.03% BTC $64,770 +1.00% VIX 19.30 +3.21% latest tape · as of 20:08 UTC · 15 Nov
The Screen · Financials · Asset Management

DoubleLine Yield Opportunities Fund

DLY · USD · Market cap $674M

FAIL · Does not pass the screen
13.02 USD

Price as of 13 Nov 2026Daily close, not a live quote

Screened 2026-11-13 · the tape above runs as of 20:08 UTC · 15 Nov · two dates, stated on purpose · verdict and workings shown in full · never trimmed

Key facts today

  • Price13.02 USD at the 13 Nov 2026 close
  • Our regime readDistribution, as of 15 Nov 2026
  • Ethical screenDoes not pass
  • Last reviewed13 Nov 2026 (3 days ago)
  • Release timesRelease and earnings times on your chart: Event Guard Mentor

A summary of the dated readings below, not a live quote and not advice.

PRICE · ONE YEAR

Our fair-value range: range not available (screen dated 2026-11-13).

Current read
Distribution ?
Screened · screened 2026-11-13
  • Trend Distribution
  • Insiders insiders bought, latest filing 2026-09-24
  • Positioning no disclosures inside 60 days, left as found
  • Options no verdict drawn today, left as found
  • Ethical does not pass the values gate
Price13.02 USD
Ethical score30.0/100
Our investment reviews on this name
2026-11-11Read Markup13.37-2.6% to today Distribution gives way to Markup first Markup read since October
2026-11-02Read Distribution13.22-1.5% to today ✓Markup gives way to Distribution first Distribution read since October
2026-10-26Read Markup13.10-0.6% to today Distribution gives way to Markup after a 6% slide in 9 weeks
2026-08-27Read Distribution13.89-6.3% to today ✓Markdown gives way to Distribution

Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.

The full research record, in depth, below
The Label · The Season, Not the Day

This name holds its distribution label.

DoubleLine Yield Opportunities Fund holds its Distribution at $13.02. Consolidating, no directional conviction, held for 6 days.

As held on the ledger · 2026-11-13
PhaseDistribution · caution
Quantitative stateConsolidating, no directional conviction, held for 6 days
Price at the screen$13.02
Valuation22.98 trailing · N/A forward price to earnings
Values screenFAIL · score 30.0
The Workings

Five Screens, Shown in Full

Does not pass. Financial sector: Financial

TestFigureLimitWhat it meansStatus
Business activity Excluded Core business clean Financial sector: Financial Fail
Debt load Excluded Below 33% Interest-bearing debt is of its assets, above the one-third ceiling the screen allows. Fail
Interest-bearing cash Excluded Below 33% Interest-bearing cash and securities are of assets, above the one-third limit. Fail
Receivables Excluded Below 49% Money owed to the company is of assets, above the 49% limit. Fail
Revenue purity Excluded Below 5% of revenue comes from non-compliant sources, over the 5% line. Fail

Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.

The Ethical Read

Why It Falls Short, in Plain English

DoubleLine Yield Opportunities Fund does not clear the screen at the business-activity stage. It operates in conventional financial services, which the screen treats as interest-based, so the financial ratios are not the deciding factor here.

Read as at 2026-11-14. It updates when the underlying figures move, and past reads are kept below.

Follow this verdict

Get an email when DLY's ethical verdict changes

Today DLY does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.

Free, no account needed. Every email has a link to stop.

The Business, in Plain Words
The fundamentals · plain-English read
Trailing P/E23.0xa premium valuation
EPS, trailing0.58
Dividend yield10.14%
52-week range13.51 - 15.75
MoatNONE
Market cap$674M

Another profit measure, before interest, tax and non-cash costs: EBITDA.

The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market.

Plain-English interpretation of our own screen data. Analysis, not advice.

The Dated Journal · Newest First, Never Edited

Every Entry, As Written

2026-11-11 Markup · changed $13.37 +1.1% Entry 10

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 1.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bullish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 1%. Insiders have been net buyers over the past quarter.

2026-11-02 Distribution · changed $13.22 +0.9% Entry 9

The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 0.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 1%. Insiders have been net buyers over the past quarter.

2026-10-26 Markup · changed $13.10 +0.0% Entry 8

The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is momentum reading neutral. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 1%. Insiders have been net buyers over the past quarter.

2026-10-16 Distribution $13.10 -1.7% Entry 7

The analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 1.7% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 1%. Insiders have been net buyers over the past quarter.

2026-10-02 Distribution $13.33 -4.0% Entry 6

Our analysis reads distribution. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 4.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 1%. Insiders have been net buyers over the past quarter.

2026-08-27 Distribution · changed $13.89 +0.0% Entry 5

The framework has shifted from markdown to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 1%.

2026-07-26 Markdown $13.89 +0.0% Entry 4

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 1%.

2026-07-18 Markdown $13.89 +0.0% Entry 3

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D, carrying a low risk profile. Technically it is sitting below its long-term trend line with momentum reading bearish. Over the past year the shares are down 2%. Our forward projection puts the odds of a 10% gain over the next month near 1%.

2026-07-03 Markdown $13.89 +0.0% Entry 2

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 0.0% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

2026-07-02 Markdown $13.89 Entry 1

Our analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns.

Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.

The Insider Ledger · Form 4 Filings, As Filed
Most recent filings · DLY
DateInsiderTitleTypeSharesValue
2026-09-24 Sherman Jeffrey J. VP P - Purchase 10,000 $130,300

Public filings, recorded as found. The full tape lives at Insider Intelligence.

What Holding Actually Paid · Price Plus Dividends
If $1,000 had been placed · historical, not a promise
PeriodPrice thenPrice returnDivs per share$1,000 becameTotal return
1 month $14.07 -1.6% $0.12 $993 -0.7%
2 months $13.90 -0.3% $0.23 $1,014 +1.4%
3 months $13.71 +1.1% $0.35 $1,037 +3.7%
6 months $13.92 -0.4% $0.70 $1,046 +4.6%
1 year $14.17 -2.2% $1.40 $1,077 +7.7%
2 years $13.00 +6.6% $2.87 $1,287 +28.7%
3 years $10.81 +28.2% $4.34 $1,683 +68.3%
5 years $12.62 +9.8% $7.14 $1,664 +66.4%

Historical returns from market close data. Past performance does not guarantee future results.

The Ledger's Promise

This entry now belongs to the ledger. Whatever DLY does next, these words stay.

DoubleLine Yield Opportunities Fund · DLY · Distribution · $13.02
Recorded 2026-11-13 · before the outcome · scored mechanically

Membership

Thirteen thousand names carry this page. One desk keeps them honest.

Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.

Join the desk

Screening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.

Get our weekly market brief free.